We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Automatically Determines Insulin Dosing for Improved Blood Sugar Control in Hospitalized Patients

By HospiMedica International staff writers
Posted on 25 Jun 2024
Print article
Image: The algorithm improves blood sugar control in hospitalized patients (Photo courtesy of 123RF)
Image: The algorithm improves blood sugar control in hospitalized patients (Photo courtesy of 123RF)

Hospitalized patients with complex dietary restrictions frequently experience hyperglycemia, or elevated blood sugar levels, which affects about one-quarter to one-half of such patients, potentially leading to severe complications, especially in those with existing diabetes. Managing blood sugar in a hospital environment is difficult due to factors like varying caloric intake, changes in organ function due to kidney or liver issues, surgical procedures, infections, and the challenges associated with intensive glucose monitoring and insulin management. To address these issues, researchers have devised a self-adjusting subcutaneous insulin algorithm (SQIA) that autonomously determines insulin doses, thereby reducing both hyperglycemia and hypoglycemia incidences and cutting down the frequency with which doctors need to issue new insulin orders.

Developed by medical experts at the University of California San Francisco (UCSF, San Francisco, CA, USA), the SQIA is an integrated calculator integrated into the medication administration record (MAR) within the electronic medical record system. Since its full implementation from September 2020 to September 2023, the SQIA has been utilized for thousands of patients subjected to dietary restrictions such as nothing by mouth (NPO), continuous tube feeds (TF), or intravenous nutrition (TPN). When physicians prescribe rapid-acting insulin under these nutritional conditions, they can opt to use the SQIA or traditional insulin (CI) dosing orders. The SQIA requires physicians to input just an initial insulin dose, which the algorithm then adjusts automatically, whereas the CI approach necessitates manual updating of insulin doses as needed.

During insulin administration, nurses input the patient's current glucose level into the MAR, and the SQIA calculates the new insulin dose based on previous insulin and glucose levels, as well as the current glucose reading. Ongoing adjustments to the algorithm and user interface, based on feedback from nurses, pharmacists, and physicians, have enhanced its precision in titrating the correct insulin dose. The research demonstrated that SQIA significantly reduced the number of insulin orders written by physicians by more than twelve times compared to CI dosing. It led to higher insulin doses in NPO and TPN diets, with a decrease in severe hyperglycemia rates and no increase in hypoglycemia, suggesting that CI orders might under-treat some patients. Moreover, the incidence of severe hyperglycemia continued to decline throughout the study, indicating ongoing improvements in SQIA's efficacy. Currently, SQIA is the preferred insulin ordering method at UCSF hospitals, chosen for about 80% of eligible patients by doctors.

“Our findings suggest that typical insulin inertia seen in adjusting insulin doses in many institutions would be overcome by an automated algorithm like the SQIA that reduces physician workload,” said UCSF endocrinologist Robert J. Rushakoff, MD, MS.

Related Links:
UCSF

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Endocavity Needle Guide
Vitro PRO
New
Pulmonary Artery Catheter
Swan-Ganz

Print article

Channels

Surgical Techniques

view channel
Image: Molecular imaging of the adrenal glands in three patients (Photo courtesy of QMUL)

Endoscopic Ultrasound-Guided Procedure Could Transform Blood Pressure Management

Primary aldosteronism (PA) is a hormonal disorder that causes high blood pressure in approximately one in 20 patients with hypertension but often goes undiagnosed and untreated. In this condition, benign... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.